5Th European Conference on Clinical and Social Research on AIDS and Drugs, Vilnius

5Th European Conference on Clinical and Social Research on AIDS and Drugs, Vilnius

Draft 100309

5th European Conference on Clinical and Social Research on AIDS and Drugs, Vilnius

Monday, April 27, 2009
9.00-16.00 / Pre-meetings
Workshops / 2nd Workshop “Collaborative Drug Abuse and HIV/AIDS Research: Regional U.S.-Eurasian Research Networks” Organised by Jacques Normand, USA
Tuesday, April 28, 2009
9.00 –16.30 /
Pre-meetings
/ Pm1. Civil Society and NGO Pre-meetings, debates. Chairs: Igor Sobolev, Estonia and Raminta Stuikyte, Lithuania
Seek and Treat: Integrated Delivery of Care and Monitoring of an Evolving Epidemic. Thomas Kerr, USA
12.00-16.30 / Pm2. Journalists sessions, special programme for journalists (in collaboration with ENCAP Project)
12.00-16.30 / Pm3. HIV and drugs psychosocial, ethic, legal aspects and role of academic community.
Debates at Mykolas Romeris university
9.00 –16.30 /
Session
/ Pm4. EU project session. Chair: Cinthia Menel-Lemos, Luxembourg
A Database on Public health Projects in North Eastern Europe and its neighbouring countries. Marek Maciejowski, Poland / European partners in action on AIDS.Marija Subataite, Lithuania / Eurosupport Project.Christiana Noestlinger, Belgium / EHRHRN project(TBC) / Oral referrals to the posters
14.00 –16.00 /
Seminar
/ Pm5. Seminar on EuroSIDA findings. Clinical, political and economical implicationsChairs: Ole Kirk and Daria Podlekareva, Denmark
14.00–16.30 / Satellite Symposium / S1. HIV epidemiology in European Region (Regional and Country Presentations). Chairs: Jeffrey V. Lazarus, Denmark, Mika Salminen,Finland
Current epidemiological HIV/AIDS situation in Former Yugoslav countries (exYC). Ljubica Bogosavljević, Serbia / HIV in Mediterranean Region, Henrique Barros, Portugal / HIV in Baltic Sea Region. Pauli Leinikki, Finland / HIV in North-Western Europe. Valerie Delpech, UK / HIV in EU Neighbourhood countries - Russia. Eduard Karamov, Russia / HIV in EU Neighbourhood countries -Ukraine. AlaScerbinskaja, Ukraine
S2. HIV and drug use in vulnerable groups. Chair: Ulrich Marcus, Germany
HIV and drug use among gay men in Berlin. Ulrich Markus,Germany / Responding to recent rises in new HIV diagnoses among MSM. Matthias Wentzlaff-Eggebert, Australia / European mapping regarding situation of prostitution across Europe and the major factors of vulnarability to HIV, TAMPEP network, Licia Brussa, The Netherlands / Drug-related harm reduction programme for migrants, presentation of AIDS & Mobility Europe. Matthias Wienold, Germany / Ethnographic risk behaviour research, Jean Paul Grund, The Netherlands
17.00- 19.00 / Opening Ceremony / Officials. from the Parliament, MOH / DGSANCO, Michael Huebel (TBC) / Zsuzzanna Jakab, Director ECDC, Sweden / EMCDDA Director / WHO / UNAIDS (TBC) / " Main results and follow-up processes on the Bremen Conference "Responsibility and partnership - together against HIV/AIDS" of the German EU presidency 2007. Ines Perea,Germany / Special lecture by Françoise Barré–Sinoussi, France (Nobel Prize 2008)(TBC)
19.00- 21.00 / Welcome Reception / Officials from the Parliament (P) and/or Ministry of Health (MOH)
Wednesday, April 29, 2009
8.30 – 9.30 / Opening session / Chairs: Officials from Minister of Health, Lithuania.
Prof. Dr. Prakash Chandra, Germany / „AIDS in the 21 century“. Prof.Dr. Robert C. Gallo, USA
9.30 – 10.30 / Plenary Sessions /
  1. HIV and Drug Use: Epidemic update. Chairs: Lucas Wiessing, EMCDDA, Portugal and Vadim Pokrovskij, Russia

HIV and AIDS in Europe: an 2007 update.Giedrius Likatavicius ,Sweden / HIV and viral hepatitis in Europe: the role of injecting drug use. Lucas Wiessing, Portugal / HIV/AIDS and viral hepatitis epidemiology in Russia. Vadim Pokrovskij,Russian AIDS centre, Russia (TBC) / ART issues - state of the art. Ole Kirk,Denmark
10.30– 11.00 /
Coffee Breaks
11.00 – 13.30 / Plenary session /
  1. Evidence based approaches to the drug users HIV epidemic control. Chairs: UNODC/ EMCDDA(TBC)

The contributions of opiate substitution treatment to HIV prevention. Ambros Uchtenhagen, Switzerland / Preventing HIV: Why bother? Elizabeth Pisani, UK / Long-term outcomes of combined HIV prevention programs for IDUs. Don Des Jarlais, USA / Drug free rehabilitation program for drug addicts and management of HIV and HCV infection. Antonio Boschini, Italy / Community presentation (TBC)
13.30 – 14.30 / Poster display / Video presentations / Lunch
14.30 – 16.30 / Parallel Sessions / A. Behavioural surveillance among IDU. Chair: Irena Klavs, Slovenia
Behavioural surveillance among IDU attached to first treatment demand (FTD) monitoring in Slovenia.Irena Klavs, Slovenia / HIV-prevalence and risk behaviors among IDUs in Tallinn, Riga, and Vilnius.(ENCAP) Kristi Rüütel, Estonia / Behavioural surveillance among IDU in Europe - harmonising methods and indicators.Lucas Wiessing, Portugal / Oral pre-sentation / Oral pre-sentation / Oral pre-sentation / Oral pre-sentation
B. HIV and Hepatitis infections. Chair: Charles Gore, Switzerland
Hepatitis awareness.Charles Gore, UK
/
Situation with HIV/Hepatitis in the WHO European region, and response to it. Irina Eramova, Denmark
/ Hepatitis C Action Plan For Scotland. Sharon Hutchinson, UK / Cost effectiveness of different interventions to eliminate HCV in IDUs. Peter Vickerman,UK / Natural History of HCV/HIV co-infection and
HCV treatment, David Thomas, USA / Discrepancy between who need treatments and not receive (TBC) / Treatment specific presentation from abstracts (TBC)
C. Drug policy. Chair: Wolfgang Heckman, Germany
From heroic to humble drug policy: Adoption of harm reduction practices in Finland. Tuukka Tammi, Finland / Alternatives to imprisonment, Netherlands or Sweden (TBC) / Presentation on 10 years policy in different countries. Raminta Stuikyte, Lithuania / Drug policies - where to begin? Arguments for a comprehensive approach. Wolfgang Heckmann, Germany / Abstract driven
Minisym-posium
/ D. Immunopathogenesis and AIDS. Chair: Guido Poli,Italy
Laboratory of Immunoregulation, a new signaling receptor for HIV. James Arthos, USA / HIV virological synapse.Quentin Sattentau,UK / Integrins in macrophage infection.José A. Esté,Spain / A new T cell subset identifying HIV+ long-term nonoprogressors. Antonio Cosma,Germany / Abstract driven
16.30 -17.30 /
Poster sessions / Video presentations
17.30 – 18.30 / Satellite Sympo-sium / S3. 20 Years with AIDS in Lithuania. Officials from the P and/or MOH / Co-chairs: Pauli Leinikki,Finland and Andrej Kozlov, Russia
Parallel sessions / Abstract driven (TBC)
20.00 – 22.30 / Gala Dinner / In Rathaus.Mayor of Vilnius, officials from the P and/or MOH

Thursday April 30, 2009

7.30 – 8.30 / MTPs -??
8.30 – 10.30 / Plenary Session /
  1. Country responses. Chairs: Pauli Leinikki, Finland and Nikos Dedes, Greece

Mrs Raelofs from Georgia / HIV service integration to PH system. Pauli Leinikki, Finland / LTSC effectiveness study in Finland. Mika Salminen, Finland / Towards effective strategy against HIV/AIDS: interaction of ethics and prevention.Andrei Kozlov, Russia / Sweden‘s AIDS policy. Gunnar Ågren or
Kerstin Käll Sweden (TBC) / Evolution of the Spanish AIDS epidemic among IDUs and the answers given by government/ NGOs from historical perspective. María J Bravo, Spain
10.30 – 11.00 / Coffee Breaks
11.00 – 13:30 / Plenary Session /
  1. Clinical and social aspects.Chairs: Maria J Bravo, Spainand Daniel Gredig, Switzerland

Social network approaches to recruitment and HIV prevention among drug users. Carl Latkin, USA / Drug Dependency treatment as HIV Prevention. Marek Chawarski, USA / No health without mental health. Applying this dictum to HIV/AIDS in Africa and Eastern Europe.Melvyn Freeman, South Africa / Third prevention goal to fight HIV in a concentrated epidemic. Roger Staub, Switzerland (TBC) / Abstract driven / Abstract driven / Abstract driven
13.30 – 14.30 /
Poster display / Video presentations / Lunch
12.00 – 13.00 / Parallel sessions / E. Harm reduction in the community and prison health. Chair: Signe Rotberga, UNODC, Lithuania
UNAIDS, UNODC and WHO guidelines on Prison health. Coordinator Jeffrey Nazarus, Denmark / CONNECTIONS Integrated responses to drugs and infections across European criminal justice systems.Cinzia Brentari, UK / Project “HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania”.Signe Rotberga, Latvia / C.R.I.S. Roll-ups. Christer Karlsson, Sweden (TBC)
F. HIV virology and molecular epidemiology. Chair: Vladimir Lukashov, The Netherlands
Molecular epidemiology of HIV in Eastern Europe. Vladimir Lukashov, The Netherlands
/
Molecular epidemiology HIV and HСV in Belarus . Vladimir Eremin, Belarus
/
Experiences from molecular typing in all new cases in a country (identifying clusters, resistance, practical arrangements etc.) Jan Albert, Sweden (TBC)
/
Prospective epidemiological study of the prevalence of HLA – B*5701 in HIV – 1 infected Patients. Adrian Streinu - Cercel, Romania
G. HIV-TB and HIV-STI co- infections. Chair: Ole Kirk, Denmark
HIV/STI co-infections in injecting drug users in Poland. Magdalena Rosinska, Poland / HIV & TB (TBC). Daria Podlekareva, Denmark / „Scaling Up Treatment And Care For HIV/AIDS And TB And Accelerating Prevention Within the Health System In the Baltic States (Estonia, Latvia, Lithuania)“,.Vilma Uzdaviniene, Lithuania / HIV, TB, and Drug Abuse Treatment. Gerry H. Friedland, USA
H.
13.00 – 14.30 /

Poster display / Lunch

Video presentations

Video presentation from Project “Expanding Network for Coordinated and Comprehensive Actions on HIV/AIDS Prevention among IDUs and Bridging Population”

/

From L‘Oreal

/

From Moscow AIDS Centre

LTC health’s and social service for IDU in Finland

/

Mission Possible

/

VERTIGO

/

HIV prevention campaign in Moscow

14.30 – 16.00 / Parallel Sessions / I. Voluntary Counselling and Testing and Nursing issues. Chair: Tarja Suominen, Finland
Guidance on Provider-initiated Voluntary Medical Examination, Testing and Counselling for Infectious Diseases in Injecting Drug Users. Hans Blystad, Norway / Nurses’ and nursing students’ knowledge and attitudes to PLHIV – comparison between Finland, Estonia and Lithuania.Tarja Suominen,Finland / VCT among drug users in Poland 2005-2007. Anna Marzec-Bogusławska, Poland / HIV counselling and treatment in Portugal.Henrique Barros, Portugal / No health without mental health. Applying this dictum to HIV/AIDS in Africa and Eastern Europe.Melvyn Freeman, South Africa
K. Dialogue between different responses to HIV epidemic among IDU.Chair: Saulius Čaplinskas, Lithuania
(Addressing, Human rights, discrimination and the importance of substitution therapy and comprehensive approach)
Strategic approaches to the HIV epidemic containment. A.Mazus, Russia / Fighting of illicit drugs epidemic in Moscow. E. Brune, Moscow,Russia / Edoardo Spacca, UK / ECAD, drugs and AIDS. Jörgen Sviden, Sweden (TBC) / ....Polish/Lithuanian (TBC)
L. Primary illegal drug use, injecting drug use and HIV prevention. Chair: Jon Sigfusson, Iceland
Primary prevention of injecting drug use. Neil Hunt (TBC) / Results of the Youth in Europe project.Alfgeir Logi Kristjansson, Iceland / Role of State Social Services for children, family and youth on HIV/AIDS prevention in Ukraine. Natalya Lukyanova, Ukraine / Oral referrals to the posters
Minisym-posium / M. Cellular and Gene Therapy of HIV-1 Infection. Chair: Dorothee von Laer, Germany
Clinicalphase II trial with autologous gene-modified haematopoietic stem cells. Geoff Symonds, Australia / Adoptive immuno gene therapy for HIV infection.Bent Jakobsen, UK / A Phase I clinical trial with
autologous gene-modified T cells for HIV infection. Jan van Lunzen, Germany / Allogeneic CCR5 delta 32 mutated stem cell transplantation for control of HIV replication. G. Hütter, Germany
16.00 -18.00 / Closing Ceremony. / Officials from the P, MOH, and EC, Video presentation from Antonio Maria Costa, Director General of UN Office at Vienna, Executive Director of Drug Control and Crime Prevention Office, Outcomes from sessions and Civil Society

1